USFDA Approvals

Lupin and Aurobindo Pharma Recall certain medications

Lupin and Aurobindo Pharma initiates nationwide recall of certain medications in the US market: The latest enforcement report of the […]

Lupin’s Posaconazole Delayed-release tablets launched into the market after receiving approval from the USFDA : On 17 February 2021, Lupin